Sam Chaloub

VANCOUVER, BC, October 29, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has granted a total of 113,200 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.40 per share for a term of 10 years. 100,000 stock

David Tsur’s 40 years of Biotech experience further strengthens the Board at a critical phase of the Company’s growth His appointment reinforces the Company’s primary focus on becoming a Biotech leader, leveraging the power of its platform technology to disrupt multiple business verticals VANCOUVER, CANADA, AND REHOVOT, ISRAEL, OCTOBER 21, 2021 – BioHarvest Sciences Inc.